Researcher Database - KIMOTO TAKASHI | Kobe Gakuin University

KIMOTO TAKASHI

Department / Course

Kobe Gakuin University The Faculty of Pharmaceutical Sciences Department of Pharmaceutical Sciences

Job Lecturer

Book and thesis
2023/07	Papers	Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity Viruses
2023/03	Papers	Induction of systemic, mucosal, and cellular immunity against SARS‐CoV‐2 in mice vaccinated by trans‐airway with a S1 protein combined with a pulmonary surfactant‐derived adjuvant SF‐10 Influenza and Other Respiratory Viruses
2023/02	Papers	A Murine Model of Food Allergy by Epicutaneous Adjuvant-Free Allergen Sensitization Followed by Oral Allergen Challenge Combined with Aspirin for Enhanced Detection of Hypersensitivity Manifestations and Immunotherapy Monitoring. Nutrients
2022/01	Papers	Development of a safe and effective novel synthetic mucosal adjuvant SF-10 derived from physiological metabolic pathways and function of human pulmonary surfactant Vaccine
2021	Papers	Cellular and Biochemical Pathogenic Processes in Severe Influenza Virus Infection: How Does Cytokine Storm Play a Role? Respiratory Disease Series: Diagnostic Tools and Disease Managements
2019/11	Papers	Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus–infected mice Journal of Dairy Science
2019/11	Papers	Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options. Biochimie
2019/01	Papers	Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice Vaccine
2018/02	Papers	Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus Comparative Immunology, Microbiology and Infectious Diseases
2018/01	Papers	Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactantmimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice PLoS ONE
2016/09	Papers	Energy metabolic disorder is a major risk factor in severe influenza virus infection: Proposals for new therapeutic options based on animal model experiments Respiratory Investigation
2016/04	Papers	Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys VACCINE
2015/04	Papers	Functional characterization of the vitamin K2 biosynthetic enzyme UBIAD1. PloS one
2015/01	Papers	Oral Administration of Lactobacillus pentosus Strain S-PT84 Enhances Anti-Influenza Virus-Specific IgG Production in Plasma after Limited Doses of Influenza Virus Vaccination in Mice J Vaccine Immunotechnology
2013/03	Papers	Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses INFLUENZA AND OTHER RESPIRATORY VIRUSES
2012/11	Papers	Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults INFLUENZA AND OTHER RESPIRATORY VIRUSES
2011/07	Papers	Surfactant protein C is an essential constituent for mucosal adjuvanticity of Surfacten, acting as an antigen delivery vehicle and inducing both local and systemic immunity VACCINE
2009/09	Papers	Influenza vaccine with Surfacten, a modified pulmonary surfactant, induces systemic and mucosal immune responses without side effects in minipigs VACCINE